How AI is transforming forecasting in pharma

Artificial Intelligence (AI) is empowering pharma companies to make smarter, faster, and more confident decisions. In this must-read article we explore the real-world impact of AI on decision-making, patient outcomes, and commercial success. Discover how you can stay ahead in a market defined by innovation and data-driven insight. What You’ll Learn: How AI could integrate […]

Share:

Download today








Artificial Intelligence (AI) is empowering pharma companies to make smarter, faster, and more confident decisions.

In this must-read article we explore the real-world impact of AI on decision-making, patient outcomes, and commercial success. Discover how you can stay ahead in a market defined by innovation and data-driven insight.

What You’ll Learn:

  • How AI could integrate vast and diverse data, from clinical trials to real-world evidence, to deliver forecasts that are not just more accurate, but more actionable for every stage of the pharma value chain.
  • Where AI-driven disease prediction and patient-centric modeling can transform R&D investment, commercial planning, and healthcare delivery, enabling earlier interventions and better outcomes.
  • Practical ways AI is revolutionizing risk assessment, portfolio optimization, and go-to-market strategies, helping organizations avoid costly pitfalls and seize new opportunities.

Download the article to find out what’s next for forecasting in pharma.

Upcoming Webinar

China Pipelines, Western Portfolios

Tuesday 14th July 3pm BST | 10am ET

Western pharma committed close to $2 billion in licensing deals and acquisitions for China-originated assets in Q1 2026 alone.

Related Content